Fulvant 250mg Injection (Fulvestrant)

Fulvant 250mg Injection is a prescription-based anticancer medicine used in the treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer, specifically in postmenopausal women. The active ingredient of the Fulvant is Fulvestrant, which belongs to the drug class of Selective Estrogen Receptor Degrader (SERD). It works by blocking and degrading estrogen receptors to slow or stop the growth of cancer cells. Fulvestrant 250mg Injection is usually given in combination with another anticancer medicine as a part of combination therapy to increase the efficacy of the treatment and treat other cancers.

The injection is administered as a slow intramuscular injection, usually into the buttock by a qualified doctor in a hospital or clinical setting. The doctor determines the dosage of the Fulvestrant 250mg injection according to the type of cancer, treatment regimen, age, and overall health of the patient. It should not be self-administered. Patients are advised not to change the dosage and timings prescribed by the doctors because it can cause severe side effects.

Common side effects include injection-site pain, nausea, weakness, tiredness, hot flashes, headache, joint or muscle pain, and decreased appetite. A few patients can undergo severe side effects, including severe breathing difficulty, swelling of the face or throat, unusual bleeding and severe abdominal pain. Most of the Fulvestrant 250mg injection side effects can leave when the body adapts to the medicine. However, report to your doctor if you experience serious side effects.

Doctors do not recommend taking this medicine during pregnancy and breastfeeding. Patients must list all medicines, supplements, and herbal products that they are taking. The Fulvestrant 250mg Injection must be used under medical oversight or medical supervision only. Attend regular tests and follow-ups to monitor the medicine response and reduce side effects. Before making any adjustments, changing the dose, or stopping the treatment, consult with your doctor to maximize the benefit.

Breast Cancer

The human body shows undesired symptoms after taking Fulvant 250mg Injection (Fulvestrant). Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.

Fulvestrant 250mg Injection (Fulvant) is a prescription-based anticancer drug. It is advised to take this injection after consulting your healthcare expert. This medicine should be given intravenously by an experienced nurse or doctor. Please do not self-administer.

● Ciruelos, E., Pascual, T., Vozmediano, M. L. A., Blanco, M., Manso, L., Parrilla, L., ... & Cortes-Funes, H. (2014). The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer. The Breast, 23(3), 201-208.
● Johnston, S. J., & Cheung, K. L. (2010). Fulvestrant-a novel endocrine therapy for breast cancer. Current medicinal chemistry, 17(10), 902-914.
● Osborne, C. K., Wakeling, A., & Nicholson, R. I. (2004). Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action. British journal of cancer, 90(1), S2-S6.
● Bross, P. F., Cohen, M. H., Williams, G. A., & Pazdur, R. (2002). FDA drug approval summaries: fulvestrant. The oncologist, 7(6), 477-480.
● Nathan, M. R., & Schmid, P. (2017). A review of fulvestrant in breast cancer. Oncology and therapy, 5(1), 17-29.